🇺🇸 FDA
Patent

US 8546322

Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof

granted A61KA61K31/495A61K38/00

Quick answer

US patent 8546322 (Inhibitors of intracellular urokinase plasminogen activator and methods of use thereof) held by The Regents of the University of California expires Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
The Regents of the University of California
Grant date
Tue Oct 01 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Sep 26 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
3
CPC classes
A61K, A61K31/495, A61K38/00, A61K47/64, A61P